絞り込み

16555

広告

2745件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Epistaxis in the setting of antithrombotic therapy: A comparison between factor Xa inhibitors, warfarin, and antiplatelet agents.

Non-vitamin K oral anticoagulants (NOAC) and the risk of myocardial infarction: Differences between factor IIa and factor Xa inhibition?

Stroke Prevention in Atrial Fibrillation - The Use of NOACs in Everyday Clinical Practice.

Non-Vitamin K Oral Anticoagulants Associated Bleeding and Its Antidotes.

Modified ROTEM for the detection of rivaroxaban and apixaban anticoagulant activity in whole blood.

The CHA₂DS₂-VASc Score Predicts Major Bleeding in Non-Valvular Atrial Fibrillation Patients Who Take Oral Anticoagulants.

The use of Apixaban for the treatment of an LV thrombus

Sub-acute leaflet thrombosis: a reversible cause of aortic stenosis

Long-term health benefits of stroke prevention with apixaban versus vitamin K antagonist warfarin in patients with non-valvular atrial fibrillation in Germany: a population-based modelling study.

A simple and fast HPLC-MS/MS method for simultaneous determination of direct oral anticoagulants apixaban, dabigatran, rivaroxaban in human plasma.

Does proton pump inhibition change the on-treatment anti-Xa activity in xabans-treated patients with atrial fibrillation? A pilot study.

Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays.

Venous Thromboembolism: A Survey of Oral Anticoagulant Preferences in the Treatment of Challenging Patient Populations.

Comparative Clinical Outcomes of Edoxaban in Adults With Nonvalvular Atrial Fibrillation.

Bleeding in patients receiving non-vitamin K oral anticoagulants: clinical trial evidence.

Laboratory Assessment of the Anticoagulant Activity of Apixaban in Patients With Nonvalvular Atrial Fibrillation.

Coagulopathies and inflammatory diseases: '…glimpse of a Snark'.

Modeling the impact of real-world adherence to once-daily (QD) versus twice-daily (BID) non-vitamin K antagonist oral anticoagulants on stroke and major bleeding events among non-valvular atrial fibrillation patients.

International consensus statement on the peri-operative management of direct oral anticoagulants in cardiac surgery.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります